Loading...


*  The Detection of Drug-Resistant HIV-1 in Taiwan - Full Text View - ClinicalTrials.gov
In the western countries, studies suggest that the prevalence of viral resistance to at least one antiretroviral drug ranges ... Drug resistance can be measured using either genotypic or phenotypic resistance assays. Genotypic assays detect mutations that ... and transmission of drug-resistant virus has been documented to be possible. The emergence of drug resistance in HIV has been ... The likelihood that a patient will acquire drug-resistant virus is related to the prevalence of drug resistance in the ...
  https://clinicaltrials.gov/show/NCT00690001?order=247
*  Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds -...
Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds ... Transmitted drug resistance mutations (TDRM) can persist in the absence of drugs for considerable time. It is generally ... Transmitted drug resistance mutations (TDRM) can persist in the absence of drugs for considerable time. It is generally ... Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds. PLoS ...
  http://www.zora.uzh.ch/id/eprint/114707/
*  Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study) - Full Text View - ClinicalTrials...
Sexually Transmitted Diseases, Viral. Sexually Transmitted Diseases. Immunologic Deficiency Syndromes. Immune System Diseases. ... Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study). This study has been completed. ... Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study). ... The secondary objective was to examine clinicians' use of HIV drug resistance testing in treatment experienced patients ...
  https://clinicaltrials.gov/show/NCT00615563?order=351
*  HIV decision support: from molecule to man | Philosophical Transactions of the Royal Society of London A: Mathematical,...
Another potential scenario concerns the transmission of drug resistance at the population level. Viral load and infectivity can ... Mutations in the viral protease that confer resistance to saquinavir increase the dissociation rate constant of the protease- ... The immune simulator takes as an input the viral load, the CD4+ count and the drug efficacy and then estimates the temporal HIV ... The MD simulation takes as an input the chemical composition of the drugs and the various mutations of the viral proteins. It ...
  http://rsta.royalsocietypublishing.org/content/367/1898/2691
*  HIV-1 RNA Quantification with Reflex to HIV-1 Genotypic Drug Resistance, Plasma - St. Lukes Hospital Cedar Rapids
... followed by genotypic determination of viral resistance to anti-HIV drugs ... then HIV-1 genotypic drug resistance mutations (HIVPR / HIV-1 Genotypic Protease and Reverse Transcriptase Inhibitor Drug ... Test Code HIVQRM HIV-1 RNA Quantification with Reflex to HIV-1 Genotypic Drug Resistance, Plasma Additional Codes. ... This test has not been cleared or approved by the U.S. Food and Drug Administration. ...
  http://stlukescedarrapids.testcatalog.org/show/HIVQRM-1
*  Brief Report: Limited Evolution of HIV Antiretroviral Drug Resistance-Associated Mutations During the Performance of Drug...
Several studies examining the utility of resistance testing have shown that a sustained reduction in HIV viral load can be ... Limited Evolution of HIV Antiretroviral Drug Resistance-Associated Mutations During the Performance of Drug Resistance Testing ... drug resistance mutations during the time taken to perform genotypic drug resistance testing. Thirty treatment-experienced ... There are few if any studies examining whether resistance is generated or continuing evolution of drug resistance mutations ...
  http://www.natap.org/2003/Jan/012703_3.htm
*  Publications and Presentations | UK HIV Drug Resistance Database
The effect of transmitted HIV-1 drug resistance on pre-therapy viral load. International HIV & Hepatitis Virus Drug Resistance ... Estimating resistance in drug experienced patients in the UK. 13th International Drug Resistance Workshop, 8-12 June 2004. * ... Bayesian models in the analysis of HIV drug resistance data from the UK HIV Drug Resistance Database. 15th International HIV ... UK HIV Drug Resistance Database. 2010. Analysis of the Degree Distribution of HIV Transmission Networks Inferred from Viral ...
  http://www.hivrdb.org.uk/publications/type/104?s=type&o=asc
*  Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy. - Oxford Vaccine Group
Consideration of HCV viral adaptation in terms of drug resistance as well as host 'immune resistance' in the STAT-C treatment ... Here, the prevalence of drug resistance mutations relevant to 27 developmental STAT-C drugs, and the potential for drug and ... is limited by the presence of drug-specific viral resistance mutations within the targeted proteins. Genetic diversity within ... at known drug resistance sites. CONCLUSION: Drug and host immune responses are likely to provide powerful selection forces that ...
  https://www.ovg.ox.ac.uk/publications/27286
*  Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients - Full Text View -...
Viral genotypic and phenotypic resistance profiles were assessed for virologic rebound (HIV-1 RNA level ≥40 c/mL). Only ... Drug: Atazanavir Drug: Ritonavir (heat-stable) Drug: Raltegravir Drug: Tenofovir/Emtricitabine Phase 4 ... Viral genotypic and phenotypic resistance profiles were assessed for virologic rebound (HIV-1 RNA level ≥40 c/mL). Only ... Viral genotypic and phenotypic resistance profiles were assessed for virologic rebound (HIV-1 RNA level ≥40 c/mL). Only ...
  https://clinicaltrials.gov/show/NCT01332227
*  Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r) - Full Text...
Any major PI mutation as defined by the most current IAS-USA Drug Resistance Mutations Figures that would adversely affect a ... Sexually Transmitted Diseases, Viral. Sexually Transmitted Diseases. Immunologic Deficiency Syndromes. Immune System Diseases. ... Active drug or alcohol use or dependence that, in the opinion of the site personnel, would interfere with adherence to the ... Note: All HIV-1 genotype profiles with ANY resistance mutations must be evaluated by a physician specializing in the care of ...
  https://clinicaltrials.gov/show/NCT00491556?order=443
*  Viral blips - Forum on HIV Drug Resistance - TheBody.com
Your doctor is certainly correct on this question of viral blips. Your last... ... Ask the Experts > Forum on HIV Drug Resistance > Q & A Viral blips. Jun 15, 2004 I have been HIV+ for exactly one year and 6 ... Your last viral load was 119. Remember that a significant change in viral load is a 0.5 log or greater change, i.e. a greater ... Six days later I had another test done and my viral load was undetectable. My doctor and I attibuted the blip to a bad case of ...
  http://www.thebody.com/Forums/AIDS/Resistance/Q157626.html
*  Viral Load and Resistance - Forum on HIV Drug Resistance - TheBody.com
I share your physicians desire to see your viral load less than 50, and while numbers like 60, 83 and 155 are more acceptable, ... Ask the Experts > Forum on HIV Drug Resistance > Q & A Viral Load and Resistance. Nov 22, 2002 Susan: I am having some issues ... Read More About HIV/AIDS Drug Resistance Browse Forums: <-- Select -->. Aging. Choosing Your Meds. En Español. In Italiano. ... assuming that you still have no drug resistance). I will agree however, that I also see people with these kinds of numbers and ...
  http://www.thebody.com/Forums/AIDS/Resistance/Q143045.html
*  HIV Drug Resistance Study Highlights Need for Viral Load Tests, Affordable Second-Line Treatments - TheBodyPRO.com
HIV Drug Resistance Study Highlights Need for Viral Load Tests, Affordable Second-Line Treatments. ... NNRTI Resistance Found in 12% of People Stopping Treatment With Undetectable Viral Load: Implications for Stock-Outs ... Authors of the study, Pretreatment HIV Drug Resistance Increases Regimen Switches in Sub-Saharan Africa, note that the numbers ... Transmitted Drug Resistance: The Other Side to the PrEP Failure Case We're Not Talking About ...
  http://www.thebodypro.com/content/76709/hiv-drug-resistance-study-highlights-need-for-vira.html?comments=on
*  Viral Load Is Not Going D own. - Forum on HIV Drug Resistance - TheBody.com
Many people who start on 2 drugs and continue on only 2 drugs for a period of time do... ... The persistence of a detectable viral load would suggest that your treatment regimen is not potent enough. ... Many people who start on 2 drugs and continue on only 2 drugs for a period of time do develop some degree of drug resistance ... Ask the Experts > Forum on HIV Drug Resistance > Q & A Viral Load Is Not Going D own.. Mar 23, 2002 I am under ART for last 2 ...
  http://www.thebody.com/Forums/AIDS/Resistance/Q133592.html?ic=4003
*  The role of the HIV-1 reverse transcriptase mutation H208Y to drug resistance and viral fitness - UCL Discovery
The role of the HIV-1 reverse transcriptase mutation H208Y to drug resistance and viral fitness. Doctoral thesis , UCL ( ... The role of the HIV-1 reverse transcriptase mutation H208Y to drug resistance and viral fitness ... The role of the HIV-1 reverse transcriptase mutation H208Y to drug resistance and viral fitness. ... Accessory mutations are thought to arise alongside major or primary drug resistance mutations in order to augment resistance, ...
  http://discovery.ucl.ac.uk/1207313/
*  Scientific paper 39 - Viral drug resistance - hVIVO
Scientific paper 39 - Viral drug resistance March 7, 2017 11:01 am Viral drug resistance ... Starting with an overview of the area, each chapter focuses on a particular target with sections on drug resistance in malaria ... Journal: Molecular Genetics of Drug Resistance, Harwood Academic Publishers, 1997, p 81-138 ... More effective antiviral drugs, vaccines and novel therapeutic drug classes at a faster pace. ...
  http://hvivo.com/scientific-paper-39-viral-drug-resistance/
*  The role of the protease cleavage sites in viral fitness and drug resistance in HIV-1 subtype C.
... ... Mutations at gag cleavage sites (CS) have been found to correlate with resistance mutations in protease (PR). Therefore, it is ... In this study, 30 subtype-C infected second-line failures were genotyped using the ViroSeqTM resistance genotyping kit and the ... only 16 had resistance mutations in PR and 23 in gag. The most frequent major PI mutations were: I54V/L, M46I, V82A, and I84V ...
  http://researchspace.ukzn.ac.za/handle/10413/9956
*  HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance - Arthur Olson
HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance Olson, Arthur J. Scripps Research Institute, ... 2016) HIV-1 Integrase Binds the Viral RNA Genome and Is Essential during Virion Morphogenesis. Cell 166:1257-1268.e12 ...
  http://grantome.com/grant/NIH/P50-GM103368-03
*  HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance - Arthur Olson
HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance Olson, Arthur J. Scripps Research Institute, ... implications of viral macromolecular interactions and dynamics and its broader impacts of the evolution of drug resistance. The ... We will explore resistance evolution in HIV as an opportune platform upon which to characterize the dynamic relationships ... HIV enzymes with their partners and effectors since they encompass key processes in the viral life cycle and as existing drug ...
  http://grantome.com/grant/NIH/P50-GM103368-01
*  Lymphopenia is induced by lymphoablative therapies and chronic viral attacks. improved - Drug Resistance to EGFR Inhibitors in...
Lymphopenia is induced by lymphoablative therapies and chronic viral attacks. improved On January 6, 2018 by Freddie Garcia ... Lymphopenia is induced by lymphoablative therapies and chronic viral attacks. improved during allograft being rejected in CB ...
  http://elevateblogconference.com/lymphopenia-is-induced-by-lymphoablative-therapies-and-chronic-viral-attacks-improved/
*  Antiretroviral drug resistance and viral tropism in HIV-1 CRF06 cpx infected patients failing antiretroviral (ARV) therapy |...
Antiretroviral drug resistance and viral tropism in HIV-1 CRF06_cpx infected patients failing antiretroviral (ARV) therapy. ... HIV-1 DRMs and tropism were detected using Stanford University Drug Resistance Database and Geno2pheno[coreceptor] 2.5. ... Aim: to describe HIV-1 drug resistance mutations (DRMs) and co-receptor tropism in antiretroviral (ARV) treatment failing ... Median viral load at the time of tropism testing was 53,326 (IQR 16,328-113,018) and median CD4+ count 184 (IQR 142-217) cells/ ...
  https://bmcinfectdis.biomedcentral.com.preview-live.oscarjournals.springer.com/articles/10.1186/1471-2334-14-S4-O22
*  Development of a platform for HIV/HCV genotyping to anti-viral drug resistance using Next Generation Sequencing - NGS...
1 Development of a platform for HIV/HCV genotyping to anti-viral drug resistance using Next Generation Sequencing - NGS ... Apresentação em tema: "Development of a platform for HIV/HCV genotyping to anti-viral drug resistance using Next Generation ... Carregar ppt "Development of a platform for HIV/HCV genotyping to anti-viral drug resistance using Next Generation Sequencing ... Development of a platform for HIV/HCV genotyping to anti-viral drug resistance using Next Generation Sequencing - NGS ...
  http://slideplayer.com.br/slide/1258643/
*  Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children - Full Text View -...
Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children. The safety and scientific ... Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children. ... If not enough of the drug is found in the blood, the dose of the drug will be increased and the amount of the drug in the blood ... monitoring drug blood levels to make sure there is enough drug to work against the virus, and changing the drug dose if it is ...
  https://clinicaltrials.gov/show/NCT00032669?order=153
*  Viral Load and Genotypic Resistance Score Predict Response to 2-Drug ART Switch
... ... HIV Drug Therapy, Glasgow 2018, October 28-31, 2018, Glasgow. Mark Mascolini. Viral load upon switching to a 2-drug ... A GSS of 1.0 indicates viral susceptibility to the regimen, 0.5 indicates possible resistance, and 0 indicates resistance [2]. ... HIV Drug Therapy, Glasgow 2018, October 28-31, 2018, Glasgow. Abstract P299.. 2. Villacian J. Basics of HIV resistance testing ...
  http://www.natap.org/2018/GLASGOW/GLASGOW_51.htm
*  Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus...
The background regimen will be constructed by the investigator based on viral resistance testing. The fully active PI will be ... Drug: Elvitegravir Drug: Raltegravir Drug: EVG placebo Drug: RAL placebo Drug: Background regimen Phase 3 ... Drug: EVG placebo Placebo to match elvitegravir administered orally once daily. Drug: Background regimen Background Regimen ( ... Drug: RAL placebo RAL placebo administered orally twice daily.. Drug: Background regimen Background Regimen (administered ...
  https://clinicaltrials.gov/show/NCT00707733?order=21